TY - JOUR
T1 - Sphingomonas Paucimobilis Bacteremia in a Patient with Major Burns Injury
T2 - A Case Report
AU - Al Maskari, Afaf
AU - Ganeshan, Ramesh
AU - Al Messabi, Ahmed
AU - Al Zaabi, Hasan
AU - Haqu, Noor Mohammad Abdul
AU - Wani, Robert Lodu Serafino
AU - Babiker, Zahir
AU - Alatoom, Adnan
AU - Jabeen, Fouzia
AU - Nsutebu, Emmanuel Fru
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Bentham Science Publisher.
PY - 2024
Y1 - 2024
N2 - Background: Sphingomonas paucimobilis is an emerging opportunistic pathogen associated with hospital and community-acquired infections. Infection is the most common cause of morbidity and mortality in burn patients. Case Presentation: We present a case of a 29-year-old lady who sustained severe burn injuries after a gas explosion at home. She was admitted to the United Arab Emirates (UAE) National Burns Unit and required several episodes of surgical debridement. She developed S. paucimobilis bloodstream infection whilst being treated with Piperacillin-tazobactam. She was subsequently treated with Meropenem for a total of 7 days after removing the source of infection, an infected central line. The S. paucimobilis isolate showed intermediate resistance to Piperacillin-tazobactam. Conclusion: Numerous case reports indicate high morbidity in patients with life-threatening S. paucimobilis infections, immunocompromised patients, and patients with underlying medical comorbidity; however, this is the first reported case from the UAE.
AB - Background: Sphingomonas paucimobilis is an emerging opportunistic pathogen associated with hospital and community-acquired infections. Infection is the most common cause of morbidity and mortality in burn patients. Case Presentation: We present a case of a 29-year-old lady who sustained severe burn injuries after a gas explosion at home. She was admitted to the United Arab Emirates (UAE) National Burns Unit and required several episodes of surgical debridement. She developed S. paucimobilis bloodstream infection whilst being treated with Piperacillin-tazobactam. She was subsequently treated with Meropenem for a total of 7 days after removing the source of infection, an infected central line. The S. paucimobilis isolate showed intermediate resistance to Piperacillin-tazobactam. Conclusion: Numerous case reports indicate high morbidity in patients with life-threatening S. paucimobilis infections, immunocompromised patients, and patients with underlying medical comorbidity; however, this is the first reported case from the UAE.
KW - Bacteremia
KW - Burns unit
KW - Central line-associated blood stream infections
KW - Hospital acquired
KW - Major burns
KW - Sphingomonas paucimobilis
UR - http://www.scopus.com/inward/record.url?scp=85176239377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176239377&partnerID=8YFLogxK
U2 - 10.2174/0102506882262684230928065501
DO - 10.2174/0102506882262684230928065501
M3 - Article
AN - SCOPUS:85176239377
SN - 0250-6882
VL - 5
JO - New Emirates Medical Journal
JF - New Emirates Medical Journal
M1 - e02506882262684
ER -